- Development of recombinant biomimetic nano-carrier for targeted gene transfer to HER3 positive breast cancer
Mahboobeh Nazari et al, 2021, International Journal of Biological Macromolecules CrossRef - Lyophilization of NOTA-sdAbs: First step towards a cold diagnostic kit for 68Ga-labeling
Henri Baudhuin et al, 2021, European Journal of Pharmaceutics and Biopharmaceutics CrossRef - Improving Targeted Delivery and Antitumor Efficacy with Engineered Tumor Necrosis Factor-Related Apoptosis Ligand-Affibody Fusion Protein
Xiaoyuan Yang et al, 2021, Molecular Pharmaceutics CrossRef - Drug Conjugates Based on a Monovalent Affibody Targeting Vector Can Efficiently Eradicate HER2 Positive Human Tumors in an Experimental Mouse Model
Tianqi Xu et al, 2020, Cancers CrossRef - [68Ga]ABY-028: an albumin-binding domain (ABD) protein-based imaging tracer for positron emission tomography (PET) studies of altered vascular permeability and predictions of albumin-drug conjugate transport
Emma Jussing et al, 2020, EJNMMI Research CrossRef - A high-risk papillomavirus 18 E7 affibody-enabled in vivo imaging and targeted therapy of cervical cancer
Ledan Wang et al, 2019, Applied Microbiology and Biotechnology CrossRef - Anti-bacterial monoclonal antibodies: next generation therapy against superbugs
Hui Wang et al, 2022, Applied Microbiology and Biotechnology CrossRef - An in vivo half-life extended prolactin receptor antagonist can prevent STAT5 phosphorylation
Shengze Yu et al, 2019, PLOS ONE CrossRef - Insights on the emerging biotechnology of histidine-rich peptides
Hèctor López-Laguna et al, 2022, Biotechnology Advances CrossRef - Directing ricin-based immunotoxins with targeting affibodies and KDEL signal peptide to cancer cells effectively induces apoptosis and tumor suppression
Seong Guk Park et al, 2022, Journal of Nanobiotechnology CrossRef - Selective disulfide reduction for labeling and enhancement of Fab antibody fragments
Terence L. Kirley et al, 2016, Biochemical and Biophysical Research Communications CrossRef - Peptide Ligands Specifically Targeting HER2 Receptor and the Role Played by a Synthetic Model System of the Receptor Extracellular Domain: Hypothesized Future Perspectives
Stefania De Luca et al, 2020, Journal of Medicinal Chemistry CrossRef - Affibody Molecules in Biotechnological and Medical Applications
Stefan Ståhl et al, 2017, Trends in Biotechnology CrossRef - Evaluation of HER2-specific peptide ligand for its employment as radiolabeled imaging probe
Hadis Honarvar et al, 2018, Scientific Reports CrossRef - Influence of Molecular Design on the Targeting Properties of ABD-Fused Mono- and Bi-Valent Anti-HER3 Affibody Therapeutic Constructs
Mohamed Altai et al, 2018, Cells CrossRef - Endosomal escape of protein nanoparticles engineered through humanized histidine-rich peptides
Hèctor López-Laguna et al, 2020, Science China Materials CrossRef - Epithelial cell adhesion molecule‑targeting designed ankyrin repeat protein‑toxin fusion Ec1‑LoPE exhibits potent cytotoxic action in prostate cancer cells
Tianqi Xu et al, 2022, Oncology Reports CrossRef - Affibody molecules as engineered protein drugs
Fredrik Y Frejd et al, 2017, Experimental & Molecular Medicine CrossRef - Affibody molecules for molecular imaging and targeted drug delivery in the management of breast cancer
Anindita De et al, 2018, International Journal of Biological Macromolecules CrossRef - Potent and specific fusion toxins consisting of a HER2‑binding, ABD‑derived affinity protein, fused to truncated versions of Pseudomonas exotoxin�A
Hao Liu et al, 2019, International Journal of Oncology CrossRef - Incorporation of a Hydrophilic Spacer Reduces Hepatic Uptake of HER2-Targeting Affibody–DM1 Drug Conjugates
Haozhong Ding et al, 2019, Cancers CrossRef - Imaging-Guided Therapy Simultaneously Targeting HER2 and EpCAM with Trastuzumab and EpCAM-Directed Toxin Provides Additive Effect in Ovarian Cancer Model
Tianqi Xu et al, 2021, Cancers CrossRef - Expression and Characterization of Intein-Cyclized Trimer of Staphylococcus aureus Protein A Domain Z
Suman Nandy et al, 2023, International Journal of Molecular Sciences CrossRef